HRP20100210T1 - Upotreba alopurinola u liječenju eritrodisestezije dlana i stopala - Google Patents
Upotreba alopurinola u liječenju eritrodisestezije dlana i stopala Download PDFInfo
- Publication number
- HRP20100210T1 HRP20100210T1 HR20100210T HRP20100210T HRP20100210T1 HR P20100210 T1 HRP20100210 T1 HR P20100210T1 HR 20100210 T HR20100210 T HR 20100210T HR P20100210 T HRP20100210 T HR P20100210T HR P20100210 T1 HRP20100210 T1 HR P20100210T1
- Authority
- HR
- Croatia
- Prior art keywords
- allopurinol
- erythrodysesthesia
- treatment
- intended
- caused
- Prior art date
Links
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 title claims abstract 10
- 229960003459 allopurinol Drugs 0.000 title claims abstract 10
- 150000003839 salts Chemical class 0.000 claims abstract 6
- 238000002512 chemotherapy Methods 0.000 claims abstract 5
- 230000002265 prevention Effects 0.000 claims abstract 5
- 239000006071 cream Substances 0.000 claims abstract 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 230000000699 topical effect Effects 0.000 claims 3
- WAVYAFBQOXCGSZ-UHFFFAOYSA-N 2-fluoropyrimidine Chemical compound FC1=NC=CC=N1 WAVYAFBQOXCGSZ-UHFFFAOYSA-N 0.000 claims 2
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 claims 2
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 claims 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 2
- 229960004117 capecitabine Drugs 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 229960002949 fluorouracil Drugs 0.000 claims 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 2
- 239000008309 hydrophilic cream Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229940016409 methylsulfonylmethane Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 235000008160 pyridoxine Nutrition 0.000 claims 1
- 239000011677 pyridoxine Substances 0.000 claims 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 claims 1
- 229940011671 vitamin b6 Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06011432A EP1862166A1 (en) | 2006-06-01 | 2006-06-01 | Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
| EP07107744 | 2007-05-08 | ||
| PCT/EP2007/055367 WO2007138103A1 (en) | 2006-06-01 | 2007-05-31 | Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20100210T1 true HRP20100210T1 (hr) | 2010-05-31 |
Family
ID=38512579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100210T HRP20100210T1 (hr) | 2006-06-01 | 2010-04-14 | Upotreba alopurinola u liječenju eritrodisestezije dlana i stopala |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US7973046B2 (ru) |
| EP (1) | EP2035006B1 (ru) |
| JP (3) | JP5028480B2 (ru) |
| KR (1) | KR101471022B1 (ru) |
| AT (1) | ATE457729T1 (ru) |
| AU (1) | AU2007267069B2 (ru) |
| CA (1) | CA2654270C (ru) |
| CY (1) | CY1110336T1 (ru) |
| DE (1) | DE602007004849D1 (ru) |
| DK (1) | DK2035006T3 (ru) |
| ES (1) | ES2341379T3 (ru) |
| HR (1) | HRP20100210T1 (ru) |
| IL (1) | IL195472A (ru) |
| MX (1) | MX2008015266A (ru) |
| NZ (1) | NZ573248A (ru) |
| PL (1) | PL2035006T3 (ru) |
| PT (1) | PT2035006E (ru) |
| RS (1) | RS51252B (ru) |
| RU (1) | RU2438673C2 (ru) |
| SI (1) | SI2035006T1 (ru) |
| WO (1) | WO2007138103A1 (ru) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2246057A1 (en) * | 2009-04-29 | 2010-11-03 | Nobera Pharma, S.L. | Use of allopurinol for the treatment of hand foot skin reaction |
| JP2013508295A (ja) | 2009-10-16 | 2013-03-07 | デューク・ユニヴァーシティ | 薬物誘発性手足症候群を治療するための組成物および方法 |
| EP2368549A1 (en) | 2010-03-25 | 2011-09-28 | BioAlliance Pharma | Treating hand-foot syndrome and related pathologies using clonidine or its derivatives |
| JP4983989B2 (ja) * | 2010-03-31 | 2012-07-25 | 小野薬品工業株式会社 | 手足症候群の予防および治療剤 |
| EP2554184B1 (en) | 2010-03-31 | 2016-10-26 | ONO Pharmaceutical Co., Ltd. | Preventive and/or remedy for hand and foot syndrome |
| JP4761000B1 (ja) * | 2010-11-08 | 2011-08-31 | 小野薬品工業株式会社 | 手足症候群の予防および／または治療剤 |
| US9259343B2 (en) | 2012-07-06 | 2016-02-16 | Newman Technologies LLC | Device for mitigating plantar fasciitis |
| EP2712613B1 (en) * | 2012-09-28 | 2017-02-08 | Pharmadab d.o.o. | Vitamin K1 and uses thereof |
| CA3017432A1 (en) * | 2016-03-28 | 2017-10-05 | Vidac Pharma Ltd. | Stable pharmaceutical compositions for topical administration and uses thereof |
| TW201927292A (zh) | 2017-12-13 | 2019-07-16 | 大陸商上海小午醫藥科技有限公司 | 一種用於預防或治療與ｅｇｆｒ被抑制相關疾病的方法 |
| CN114028568A (zh) | 2018-04-16 | 2022-02-11 | 上海岸阔医药科技有限公司 | 预防或治疗肿瘤疗法副作用的方法 |
| RU2722396C2 (ru) * | 2018-07-11 | 2020-05-29 | Федеральное государственное бюджетное учреждение дополнительного профессионального образования "Центральная государственная медицинская академия" Управления делами Президента Российской Федерации (ФГБУ ДПО "ЦГМА") | Способ лечения пальмарно-плантарной эритродизестезии |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3011A (en) * | 1843-03-21 | Improvement in water-wheels | ||
| DE3772193D1 (de) | 1987-02-13 | 1991-09-19 | Allergan Pharma | Verwendung von pteridinen und/oder purinen oder eines xanthinoxidase-hemmers zur herstellung eines arzneimittels zur behandlung von genetisch bedingten degenerativen netzhauterkrankungen. |
| JPH03106817A (ja) | 1989-09-20 | 1991-05-07 | Nippon Kayaku Co Ltd | アロプリノール製剤 |
| JPH066700A (ja) | 1992-06-22 | 1994-01-14 | Fujitsu General Ltd | ハイビジョン受像機 |
| WO1994005293A1 (en) | 1992-09-04 | 1994-03-17 | Aws Shakir Mustafa Salim | Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol |
| GB9218711D0 (en) | 1992-09-04 | 1992-10-21 | Salim Aws S M | Skin cancer treatment |
| JP3106817B2 (ja) | 1993-11-02 | 2000-11-06 | 富士電機株式会社 | 漏電遮断器 |
| US6284234B1 (en) * | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
| US6060083A (en) | 1999-04-01 | 2000-05-09 | Topical Technologies, Inc. | Topical DMSO treatment for palmar-plantar erythrodysethesia |
| AU2001267533A1 (en) | 2000-06-20 | 2002-01-02 | Henkel Kommanditgesellschaft Auf Aktien | Structure-improving hair care agents |
| DE60117043T2 (de) | 2000-11-22 | 2006-07-13 | Rxkinetix, Inc., Louisville | Behandlung von mukositis |
| US7544348B2 (en) | 2001-02-15 | 2009-06-09 | Access Pharmaceuticals, Inc. | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| ATE429947T1 (de) * | 2001-08-29 | 2009-05-15 | Pharmakodex Ltd | Vorrichtung zur topischen verabreichung |
| CA2466869C (en) * | 2001-11-29 | 2010-01-19 | Sound Pharmaceuticals Incorporated | Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| DE10200578A1 (de) * | 2002-01-09 | 2003-07-10 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme |
| US6979688B2 (en) * | 2002-02-12 | 2005-12-27 | Ford John P | Treatment method against side-effects of chemotherapy |
| US20040214215A1 (en) * | 2003-03-07 | 2004-10-28 | Yu Ruey J. | Bioavailability and improved delivery of alkaline pharmaceutical drugs |
| JP2007501865A (ja) | 2003-06-11 | 2007-02-01 | ノバセア インコーポレイティッド | 放射線治療薬および放射線治療と併用した、活性ビタミンｄ化合物による癌の治療法 |
| AU2004247108A1 (en) | 2003-06-11 | 2004-12-23 | Novacea, Inc | Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents |
| US20050148906A1 (en) | 2003-12-24 | 2005-07-07 | Gregory Skover | Apparatus for treatment of the skin having a signaling marker |
| CA2557814A1 (en) * | 2004-03-01 | 2005-09-15 | Lumen Therapeutics, Llc | Compositions and methods for treating diseases |
| JP4405326B2 (ja) | 2004-06-28 | 2010-01-27 | 株式会社東芝 | ランドリー機器 |
| EP1802292A4 (en) * | 2004-09-17 | 2008-02-13 | Biomas Ltd | COMPOSITIONS AND METHODS FOR TRIGGERING HAIR GROWTH |
-
2007
- 2007-05-31 ES ES07729768T patent/ES2341379T3/es active Active
- 2007-05-31 JP JP2009512609A patent/JP5028480B2/ja not_active Expired - Fee Related
- 2007-05-31 WO PCT/EP2007/055367 patent/WO2007138103A1/en active Application Filing
- 2007-05-31 NZ NZ573248A patent/NZ573248A/en not_active IP Right Cessation
- 2007-05-31 DK DK07729768.7T patent/DK2035006T3/da active
- 2007-05-31 EP EP07729768A patent/EP2035006B1/en active Active
- 2007-05-31 RS RSP-2010/0163A patent/RS51252B/sr unknown
- 2007-05-31 MX MX2008015266A patent/MX2008015266A/es active IP Right Grant
- 2007-05-31 US US12/227,807 patent/US7973046B2/en not_active Expired - Fee Related
- 2007-05-31 RU RU2008152341/15A patent/RU2438673C2/ru not_active IP Right Cessation
- 2007-05-31 AU AU2007267069A patent/AU2007267069B2/en not_active Ceased
- 2007-05-31 AT AT07729768T patent/ATE457729T1/de active
- 2007-05-31 SI SI200730172T patent/SI2035006T1/sl unknown
- 2007-05-31 DE DE602007004849T patent/DE602007004849D1/de active Active
- 2007-05-31 PL PL07729768T patent/PL2035006T3/pl unknown
- 2007-05-31 CA CA2654270A patent/CA2654270C/en not_active Expired - Fee Related
- 2007-05-31 PT PT07729768T patent/PT2035006E/pt unknown
-
2008
- 2008-11-24 IL IL195472A patent/IL195472A/en not_active IP Right Cessation
- 2008-12-31 KR KR1020087032168A patent/KR101471022B1/ko not_active IP Right Cessation
-
2010
- 2010-03-23 CY CY20101100279T patent/CY1110336T1/el unknown
- 2010-04-14 HR HR20100210T patent/HRP20100210T1/hr unknown
-
2011
- 2011-05-24 US US13/114,768 patent/US8557829B2/en not_active Expired - Fee Related
-
2012
- 2012-05-23 JP JP2012118062A patent/JP5389980B2/ja not_active Expired - Fee Related
-
2013
- 2013-09-09 US US14/021,723 patent/US20140011820A1/en not_active Abandoned
- 2013-10-09 JP JP2013211700A patent/JP2014028851A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20100210T1 (hr) | Upotreba alopurinola u liječenju eritrodisestezije dlana i stopala | |
| JP2009542581A5 (ru) | ||
| BRPI1014433A2 (pt) | "derivado de um composto ou um sal farmaceuticamente aceitável, composição farmacêutica ou nutracêutica, e métodos para tratar uma condição, para reduzir o desenvolvimento à tolerância a medicamentos vasodilatadores, para estimular a função mitocondrial em células, para melhorar a estrutura ou a função muscular em um animal e os efeitos mitocondriais associados com exercício em um animal, para intensificar a capacidade de exercício em um animal, a saúde e a função muscular, e a recuperação de músculos de atividade vigorosa ou do dano associado com atividade vigorosa ou sustentada em um animal, e, usos de epicatequina ou um derivado de epicatequina, de nicorandil ou um derivado de nicorandil e suas combinações." | |
| JP2010525050A5 (ru) | ||
| BR0207024A (pt) | Medicamento com ação inicial rápida para o tratamento de disfunção sexual | |
| HRP20120798T1 (hr) | Kappa-opijatni agonisti za lijeäśenje dijareja-predominantnog i naizmjeniäśnog sindroma iritabilnog crijeva | |
| HRP20150375T1 (hr) | Derivati piridazinona | |
| JP2013511534A5 (ru) | ||
| BRPI0513673B8 (pt) | método para produzir um medicamento para aumentar a eficácia e o transporte dos compostos biologicamente ativos enteralmente administrados, e composição farmacêutica | |
| WO2007064448A3 (en) | Cancer treatment using fts and 2-deoxyglucose | |
| US20170333463A1 (en) | Compositions and formulations of glucosamine for transdermal and transmucosal administration | |
| HRP20192246T1 (hr) | Marker za poremećaje kisele sfingomijelinaze i njegova uporaba | |
| AU2020278236A8 (en) | Methods of treating Sjögren's Syndrome using a Bruton's tyrosine kinase inhibitor | |
| JP2016505050A5 (ru) | ||
| RU2011148355A (ru) | Применение аллопуринола для ладонно-родошвенного синдрома | |
| AR033390A1 (es) | Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes | |
| Tubridy et al. | Which drugs are most effective for recurrent herpes labialis? | |
| JP2012525358A5 (ru) | ||
| HRP20110127T1 (hr) | Aksomadol za liječenje kod artritisa | |
| HRP20151241T1 (hr) | Upotreba s-adenozilmetionina (sam) i superoksid-dismutaze (sod) za pripravu lijekova za lijeäśenje alzheimerove bolesti | |
| NZ584968A (en) | Novel antiretroviral combination comprising ritonavir and atazanavir | |
| CN102058699B (zh) | 一种治疗尘肺的药物 | |
| HRP20231448T1 (hr) | Primjena delgocitiniba za liječenje kroničnog ekcema ruku | |
| BRPI0918593A2 (pt) | composição farmacêutica para uso no tratamento de infecções transmitidas sexualmente | |
| JP2017511307A5 (ru) |